All Stories

  1. Hypokalemic periodic paralysis presenting as cardiac arrest
  2. Dihydrotestosterone: paracrine role in the prostate and endocrine systemic effects.
  3. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
  4. Novel Lipoprotein Subfraction and Size Measurements in Prediction of Mortality in Maintenance Hemodialysis Patients
  5. Well differentiated follicular thyroid neoplasia: Impact of molecular and technological advances on detection, monitoring and treatment
  6. National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events
  7. Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity
  8. Serum Thyroglobulin Measurement by LC-MSMS in the Presence of Autoantibodies.
  9. Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults
  10. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: Total and free testosterone reference ranges
  11. Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
  12. Corrigendum to “Interlaboratory comparison study of serum total testosterone measurements performed by mass spectrometry methods” [Steroids 74 (6) (2009) 498–503]
  13. Interlaboratory comparison study of serum total testoserone measurements performed by mass spectrometry methods
  14. Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States
  15. In Reply
  16. In Reply
  17. Direct Determination of Lipoprotein Particle Sizes and Concentrations by Ion Mobility Analysis
  18. Vitamin D2Is as Effective as Vitamin D3in Maintaining Circulating Concentrations of 25-Hydroxyvitamin D
  19. Un neuropeptide à l’origine du vieillissement testiculaire ?
  20. Expression of endometrial glycogen synthase kinase-3  protein throughout the menstrual cycle and its regulation by progesterone
  21. Disruption of POF1B Binding to Nonmuscle Actin Filaments Is Associated with Premature Ovarian Failure
  22. Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice
  23. XXY Mice Exhibit Gonadal and Behavioral Phenotypes Similar to Klinefelter Syndrome
  24. Conditions Affecting Sertoli Cells
  25. Leydig cell hypoplasia due to inactivation of luteinizing hormone receptor by a novel homozygous nonsense truncation mutation in the seventh transmembrane domain
  26. Klinefelter syndrome: Expanding the phenotype and identifying new research directions
  27. Variations in endometrial expression of active and inactive forms of glycogen synthase kinase-3 β protein during the menstrual cycle
  28. Evidence for a Role of Glycogen Synthase Kinase-3β in Rodent Spermatogenesis
  29. Spermatogenetic Expression of RNA-Binding Motif Protein 7, a Protein That Interacts With Splicing Factors
  30. Impairment of Spermatogenesis in Transgenic Mice With Selective Overexpression of Bcl-2 in the Somatic Cells of the Testis
  31. XXY Male Mice: An Experimental Model for Klinefelter Syndrome1
  32. XXY Male Mice: An Experimental Model for Klinefelter Syndrome
  33. Redistribution of Bax Is an Early Step in an Apoptotic Pathway Leading to Germ Cell Death in Rats, Triggered by Mild Testicular Hyperthermia1
  34. Chlamydia trachomatis Can Persist in Joint Tissue After Antibiotic Treatment in Chronic Reiterʼs Syndrome / Reactive Arthritis
  35. Prolactin disorders
  36. Identification of a cAMP-dependent protein-dan interaction at a sequence near the yeast mitochondrial rRNA genes
  37. In Situ Hybridization for Detection of Inapparent Infection With Chlamydia trachomatis in Synovial Tissue of a Patient With Reiter’s Syndrome
  38. Maternal Hyperlipidemia in Pregnancy
  39. Acute Endocrinopathies during Pregnancy
  40. Effect of improved assay sensitivity on luteinizing hormone pulse detection after gonadotropin-releasing hormone antagonist treatment in man.
  41. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
  42. Male contraception: Achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone enanthate
  43. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men